BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 26462893)

  • 41. Venous Thrombosis Risk after Cast Immobilization of the Lower Extremity: Derivation and Validation of a Clinical Prediction Score, L-TRiP(cast), in Three Population-Based Case-Control Studies.
    Nemeth B; van Adrichem RA; van Hylckama Vlieg A; Bucciarelli P; Martinelli I; Baglin T; Rosendaal FR; le Cessie S; Cannegieter SC
    PLoS Med; 2015 Nov; 12(11):e1001899; discussion e1001899. PubMed ID: 26554832
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pathologic fibrin formation and cold-induced clotting of membrane oxygenators during cardiopulmonary bypass.
    Blombäck M; Kronlund P; Aberg B; Fatah K; Hansson LO; Egberg N; Moor E; Carlsson K
    J Cardiothorac Vasc Anesth; 1995 Feb; 9(1):34-43. PubMed ID: 7718753
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diagnostic accuracy of the Triage D-dimer test for exclusion of venous thromboembolism in outpatients.
    Ghys T; Achtergael W; Verschraegen I; Leus B; Jochmans K
    Thromb Res; 2008; 121(6):735-41. PubMed ID: 17888501
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Activated-protein-C resistance in cancer patients.
    Green D; Maliekel K; Sushko E; Akhtar R; Soff GA
    Haemostasis; 1997; 27(3):112-8. PubMed ID: 9306127
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased ADAMTS13 activity in patients with venous thromboembolism.
    Mazetto BM; Orsi FL; Barnabé A; De Paula EV; Flores-Nascimento MC; Annichino-Bizzacchi JM
    Thromb Res; 2012 Dec; 130(6):889-93. PubMed ID: 23031329
    [TBL] [Abstract][Full Text] [Related]  

  • 46. D-dimer before chemotherapy might predict venous thromboembolism.
    Arpaia G; Carpenedo M; Verga M; Mastrogiacomo O; Fagnani D; Lanfredini M; Milani M; Cimminiello C
    Blood Coagul Fibrinolysis; 2009 Apr; 20(3):170-5. PubMed ID: 19276795
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Venous thromboembolism after spine surgery: changes of the fibrin monomer complex and D-dimer level during the perioperative period.
    Yoshioka K; Kitajima I; Kabata T; Tani M; Kawahara N; Murakami H; Demura S; Tsubokawa T; Tomita K
    J Neurosurg Spine; 2010 Nov; 13(5):594-9. PubMed ID: 21039150
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Risk Factors Associated with Venous Thromboembolism after Lung Cancer Surgery: A Single-center Study].
    Cui S; Li H; Tian B; Song C; Hu B
    Zhongguo Fei Ai Za Zhi; 2018 Oct; 21(10):753-760. PubMed ID: 30309426
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Risk Factors of VTE and Survival Prognosis of Patients With Malignant Cancer: Implication for Nursing and Treatment.
    Qi Y; Hu X; Chen J; Ying X; Shi Y
    Clin Appl Thromb Hemost; 2020; 26():1076029620971053. PubMed ID: 33119403
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mechanisms and mitigating factors for venous thromboembolism in chronic kidney disease: the REGARDS study.
    Cheung KL; Zakai NA; Callas PW; Howard G; Mahmoodi BK; Peralta CA; Judd SE; Kurella Tamura M; Cushman M
    J Thromb Haemost; 2018 Sep; 16(9):1743-1752. PubMed ID: 29984467
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Correlation between von Willebrand factor antigen, von Willebrand factor ristocetin cofactor activity and factor VIII activity in plasma.
    Lippi G; Franchini M; Salvagno GL; Montagnana M; Poli G; Guidi GC
    J Thromb Thrombolysis; 2008 Oct; 26(2):150-3. PubMed ID: 17786534
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE).
    Tsai AW; Cushman M; Rosamond WD; Heckbert SR; Tracy RP; Aleksic N; Folsom AR
    Am J Med; 2002 Dec; 113(8):636-42. PubMed ID: 12505113
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Age and gender specific cut-off values to improve the performance of D-dimer assays to predict the risk of venous thromboembolism recurrence.
    Legnani C; Cini M; Cosmi B; Carraro P; Tripodi A; Erba N; Palareti G
    Intern Emerg Med; 2013 Apr; 8(3):229-36. PubMed ID: 21584847
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prospective evaluation of protein C and factor VIII in prediction of cancer-associated thrombosis.
    Tafur AJ; Dale G; Cherry M; Wren JD; Mansfield AS; Comp P; Rathbun S; Stoner JA
    Thromb Res; 2015 Dec; 136(6):1120-5. PubMed ID: 26475410
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pretreatment plasma D-dimer, fibrinogen, and platelet levels significantly impact prognosis in patients with epithelial ovarian cancer independently of venous thromboembolism.
    Man YN; Wang YN; Hao J; Liu X; Liu C; Zhu C; Wu XZ
    Int J Gynecol Cancer; 2015 Jan; 25(1):24-32. PubMed ID: 25347092
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical analysis of postoperative venous thromboembolism risk factors in lung cancer patients.
    Yang Y; Zhou Z; Niu XM; Li ZM; Chen ZW; Jian H; Ai XH; Cheng BJ; Liao ML; Lu S
    J Surg Oncol; 2012 Nov; 106(6):736-41. PubMed ID: 22711667
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Coagulation biomarkers are independent predictors of increased oxygen requirements in COVID-19.
    Rauch A; Labreuche J; Lassalle F; Goutay J; Caplan M; Charbonnier L; Rohn A; Jeanpierre E; Dupont A; Duhamel A; Faure K; Lambert M; Kipnis E; Garrigue D; Lenting PJ; Poissy J; Susen S
    J Thromb Haemost; 2020 Nov; 18(11):2942-2953. PubMed ID: 32881304
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tissue Factor Pathway Inhibitor 2: A Novel Biomarker for Predicting Asymptomatic Venous Thromboembolism in Patients with Epithelial Ovarian Cancer.
    Yamanaka S; Miyake R; Yamada Y; Kawaguchi R; Ootake N; Myoba S; Kobayashi H
    Gynecol Obstet Invest; 2022; 87(2):133-140. PubMed ID: 35613543
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of selected prothrombotic and proinflammatory factors on the incidence of venous thrombosis after pacemaker implantation.
    Lelakowski J; Domagała TB; Rydlewska A; Januszek R; Kotula Horowitz K; Majewski J; Ząbek A; Małecka B; Musiał J
    Kardiol Pol; 2012; 70(3):260-7. PubMed ID: 22430407
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Soluble Vascular Endothelial Growth Factor (sVEGF) and the Risk of Venous Thromboembolism in Patients with Cancer: Results from the Vienna Cancer and Thrombosis Study (CATS).
    Posch F; Thaler J; Zlabinger GJ; Königsbrügge O; Koder S; Zielinski C; Pabinger I; Ay C
    Clin Cancer Res; 2016 Jan; 22(1):200-6. PubMed ID: 26302981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.